GETTING MY RAW MATERIALS TO WORK

“The present predicament has exposed some structural weaknesses in the EU’s medicines offer chain plus a superior dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides claimed. She advised that offer chain challenges be resolved within an EU pharmaceutical tactic anticipated to be released by the tip of the year.="